- Home
- ALVO vs NFJ Comparison
ALVO vs NFJ Comparison
Compare ALVO & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALVO | NFJ |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALVO | NFJ |
|---|---|---|
| Price | $4.77 | $13.27 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | ★ 566.9K | 223.5K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $573,350,000.00 | N/A |
| Revenue This Year | $20.85 | N/A |
| Revenue Next Year | $44.49 | N/A |
| P/E Ratio | $19.40 | ★ N/A |
| Revenue Growth | ★ 45.55 | N/A |
| 52 Week Low | $4.32 | $10.45 |
| 52 Week High | $13.70 | $12.86 |
Technical Indicators
Market Signals| Indicator | ALVO | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 66.43 |
| Support Level | $4.40 | $12.83 |
| Resistance Level | $5.23 | $13.02 |
| Average True Range (ATR) | 0.27 | 0.10 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 39.03 | 95.47 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.